Six insights from the company’s fourth-quarter financial report, published Jan. 27:
1. In the fourth quarter, orthopedics and spine net sales increased 12.5 percent year over year to $2.1 billion. Full-year net sales were $7.6 billion, representing a 26 percent increase compared with 2020 and an 18.1 percent increase compared with 2019.
2. Fourth-quarter medsurg and neurotechnology net sales increased 8.7 percent year over year to $2.6 billion. Net sales in 2021 were $9.5 billion, a 14.3 percent increase compared with 2020 and a 12.6 percent increase compared with 2019.
3. Stryker’s reported net earnings of $662 million in the fourth quarter and $2 billion for 2021 increased 16.5 percent and 24.7 percent, respectively.
4. Organic net sales growth in 2022 is expected to be in the range of 6 to 8 percent, the company said.
5. Stryker continues to assess the effect the COVID-19 pandemic will have on its operations and financial results but said the “short-term outlook remains volatile.”
6. “We delivered a strong year of financial results, despite the ongoing challenges of the pandemic,” said Kevin Lobo, chair and CEO. “Organic sales growth of over 7 percent versus 2019, coupled with double-digit adjusted [earnings per share] growth and excellent cash flow performance were all noteworthy achievements, as was the excellent integration of Wright Medical. We continue to be well-positioned for future growth.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
